#USA #Waltham #Nordic Capital #ArisGlobal #Dassault Systèmes

Nordic Capital's Strategic Sale of ArisGlobal to Dassault Systèmes

In a significant development within the life sciences software sector, Nordic Capital has revealed its agreement to sell ArisGlobal to Dassault Systèmes. This strategic move not only concludes Nordic Capital's partnership with the innovative software provider but also highlights the transformation of ArisGlobal into a formidable player in the life sciences arena.

Founded in 1989 and with its headquarters in Waltham, Massachusetts, ArisGlobal has established itself as a leader in providing software solutions that cater to the regulatory and safety needs of the life sciences industry. The company’s flagship product, the LifeSphere® platform, has seen extensive enhancements under Nordic Capital’s ownership, evolving into an advanced, cloud-native solution that integrates regulatory submissions, pharmacovigilance, and clinical data management seamlessly.

The journey began when Nordic Capital invested in ArisGlobal in 2019, focusing on modernizing the technology and expanding the company’s commercial reach. With a robust strategy that emphasized SaaS transition and product diversification, Nordic Capital played a pivotal role in strengthening ArisGlobal’s market positioning. The efforts bore fruit with the integration of AI capabilities into the platform, notably with the launch of NavaX, a generative AI solution designed to automate and optimize pharmacovigilance workflows. This innovation has attracted attention among major pharmaceutical companies, emphasizing ArisGlobal’s forward-looking approach in technology application.

Aman Wasan, CEO of ArisGlobal, noted, "The life sciences industry is at an inflection point due to increasing regulatory complexities and vast data volumes. Our collaboration with Nordic Capital provided us with the necessary resources to innovate and implement cutting-edge solutions like NavaX. Through this arrangement, we not only met the industry's needs but also set trends in innovation."

The company's achievements during Nordic Capital's stewardship include expanding its client base to over 200 life sciences firms and processing over 12 million safety cases annually, reflecting robust revenue growth, with projections of about USD 175 million in 2026. This remarkable performance is attributed to ArisGlobal's adept handling of the complexities associated with regulatory compliance, which has grown significantly in recent years.

With the acquisition, Dassault Systèmes aims to enhance its portfolio by integrating ArisGlobal’s AI-driven regulatory software into its framework, thereby creating a more comprehensive suite of services for the life sciences sector. The combined strength of both firms promises an unmatched offering across the life sciences value chain, enhancing capabilities in research, clinical development, and manufacturing.

Daniel Berglund, Partner and Head of Healthcare at Nordic Capital Advisors, commented, "This transaction signifies the culmination of a successful partnership that transformed ArisGlobal into a scalable and innovative enterprise. We're excited to see how the alignment with Dassault Systèmes will further advance ArisGlobal’s mission."

As the deal progresses through the necessary regulatory approvals, both firms are poised to harness the strengths of their respective innovations. The completed transaction is anticipated to enhance ArisGlobal’s growth potential, leveraging Dassault Systèmes' wide-reaching customer network and investment capacity.

In conclusion, the sale of ArisGlobal not only marks the fruition of Nordic Capital’s commitment to empowering companies but also sets the stage for a significant leap in life sciences software capabilities. By embracing AI and enhancing regulatory compliance tools, the newly united entity is expected to drive forward the agenda of innovation in this critical field.